| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
206,015 |
169,148 |
$36.16M |
| G0378 |
Hospital observation service, per hour |
42,333 |
31,676 |
$27.38M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
240,282 |
204,376 |
$24.50M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
105,125 |
85,877 |
$24.31M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
355,806 |
311,459 |
$19.47M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
6,393 |
5,168 |
$14.18M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
322,995 |
277,959 |
$12.91M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,990 |
1,300 |
$12.26M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
10,976 |
9,038 |
$8.55M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
53,114 |
46,652 |
$7.62M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
35,653 |
31,098 |
$6.43M |
| 86902 |
|
21,040 |
7,108 |
$6.07M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
7,600 |
6,118 |
$5.90M |
| 99215 |
Prolong outpt/office vis |
73,018 |
61,562 |
$5.37M |
| 99469 |
Subsequent inpatient neonatal critical care, per day, 28 days or younger |
20,497 |
3,739 |
$5.26M |
| 99233 |
Prolong inpt eval add15 m |
115,857 |
37,788 |
$5.16M |
| 99472 |
Subsequent inpatient pediatric critical care, per day, 2-5 years |
20,840 |
2,997 |
$4.91M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
28,970 |
25,511 |
$4.58M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
131,523 |
47,005 |
$4.56M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
26,489 |
15,278 |
$4.44M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
40,792 |
32,299 |
$4.32M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
53,463 |
47,001 |
$3.54M |
| 86885 |
|
47,024 |
33,042 |
$3.42M |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
1,969 |
1,779 |
$3.27M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
32,204 |
28,440 |
$3.11M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19,235 |
12,652 |
$3.08M |
| 94375 |
|
22,412 |
19,669 |
$3.03M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,655 |
1,323 |
$2.92M |
| J2323 |
Injection, natalizumab, 1 mg |
1,727 |
1,456 |
$2.87M |
| 77386 |
|
12,195 |
973 |
$2.84M |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
26,750 |
23,467 |
$2.84M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
84,517 |
21,625 |
$2.79M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
6,189 |
5,390 |
$2.77M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
1,101 |
765 |
$2.77M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
118,075 |
102,567 |
$2.71M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
22,817 |
8,607 |
$2.64M |
| 71045 |
Radiologic examination, chest; single view |
239,658 |
157,448 |
$2.62M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
320,888 |
260,363 |
$2.55M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
32,844 |
29,267 |
$2.53M |
| 86900 |
|
47,838 |
33,442 |
$2.52M |
| 36430 |
|
13,172 |
8,259 |
$2.51M |
| 76820 |
|
67,811 |
43,117 |
$2.51M |
| 99479 |
Subsequent intensive care, per day, very low birth weight infant |
26,744 |
6,018 |
$2.47M |
| 54161 |
|
2,541 |
2,249 |
$2.46M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
6,592 |
5,698 |
$2.42M |
| 42830 |
|
1,515 |
1,145 |
$2.39M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
30,836 |
28,292 |
$2.33M |
| J9312 |
Injection, rituximab, 10 mg |
916 |
533 |
$2.31M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
75,636 |
63,521 |
$2.28M |
| 20680 |
|
1,668 |
1,283 |
$2.28M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
47,975 |
26,046 |
$2.22M |
| J2357 |
Injection, omalizumab, 5 mg |
2,292 |
915 |
$2.21M |
| 99243 |
|
28,575 |
24,902 |
$2.13M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
23,485 |
20,103 |
$2.09M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19,008 |
12,896 |
$2.08M |
| 71046 |
Radiologic examination, chest; 2 views |
77,369 |
64,528 |
$2.04M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
60,216 |
42,168 |
$2.02M |
| 64642 |
|
9,411 |
8,008 |
$1.98M |
| 80053 |
Comprehensive metabolic panel |
222,646 |
166,419 |
$1.97M |
| 95812 |
|
15,180 |
13,179 |
$1.93M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25,447 |
21,844 |
$1.90M |
| 76770 |
|
34,387 |
30,375 |
$1.90M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
11,425 |
7,154 |
$1.87M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,931 |
3,744 |
$1.80M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14,973 |
12,380 |
$1.78M |
| J0897 |
Injection, denosumab, 1 mg |
2,674 |
2,195 |
$1.73M |
| 70450 |
Computed tomography, head or brain; without contrast material |
47,485 |
41,068 |
$1.71M |
| 87428 |
|
23,300 |
20,292 |
$1.69M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43,107 |
32,275 |
$1.66M |
| 93304 |
|
11,346 |
9,268 |
$1.64M |
| J9299 |
Injection, nivolumab, 1 mg |
279 |
195 |
$1.58M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
60,503 |
53,804 |
$1.54M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
22,925 |
20,346 |
$1.50M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
256,322 |
185,772 |
$1.44M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14,045 |
12,597 |
$1.41M |
| A0436 |
Rotary wing air mileage, per statute mile |
1,964 |
1,773 |
$1.38M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
53,872 |
34,533 |
$1.37M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
38,347 |
11,113 |
$1.35M |
| 88307 |
|
15,018 |
12,102 |
$1.34M |
| 81229 |
|
2,919 |
2,516 |
$1.33M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
53,907 |
34,544 |
$1.27M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
82,205 |
39,611 |
$1.25M |
| 92587 |
|
7,797 |
6,844 |
$1.19M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
23,757 |
20,359 |
$1.15M |
| 90791 |
Psychiatric diagnostic evaluation |
13,764 |
11,589 |
$1.15M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
26,423 |
20,536 |
$1.14M |
| J9035 |
Injection, bevacizumab, 10 mg |
723 |
560 |
$1.12M |
| 74018 |
|
70,404 |
48,060 |
$1.12M |
| 49580 |
|
567 |
480 |
$1.12M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16,899 |
15,281 |
$1.11M |
| 36415 |
Collection of venous blood by venipuncture |
367,472 |
271,260 |
$1.11M |
| 95716 |
|
2,369 |
1,176 |
$1.10M |
| 86923 |
|
15,615 |
6,149 |
$1.10M |
| 95951 |
|
3,235 |
1,418 |
$1.07M |
| 86922 |
|
12,464 |
4,563 |
$1.05M |
| 90837 |
Psychotherapy, 53 minutes with patient |
13,975 |
8,853 |
$1.04M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,598 |
2,196 |
$1.02M |
| 99238 |
Hospital discharge day management, 30 minutes or less |
21,830 |
19,189 |
$1.02M |
| J0475 |
Injection, baclofen, 10 mg |
1,701 |
1,431 |
$1.02M |
| J1951 |
Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg |
64 |
40 |
$1.02M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
25,835 |
20,946 |
$1.01M |
| 72082 |
|
16,643 |
14,395 |
$1.00M |
| 99480 |
Subsequent intensive care, per day, low birth weight infant |
11,611 |
2,386 |
$986K |
| 86920 |
|
11,038 |
4,379 |
$982K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
622 |
417 |
$927K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
21,666 |
18,639 |
$908K |
| 36512 |
|
1,449 |
1,209 |
$890K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
1,413 |
1,091 |
$886K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,411 |
1,790 |
$884K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20,615 |
16,592 |
$837K |
| 84443 |
Thyroid stimulating hormone (TSH) |
64,687 |
54,854 |
$833K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
15,762 |
13,389 |
$830K |
| 99223 |
Prolong inpt eval add15 m |
11,601 |
9,672 |
$829K |
| 72170 |
|
16,158 |
14,129 |
$784K |
| 86901 |
|
47,836 |
33,437 |
$778K |
| 77077 |
|
13,431 |
11,685 |
$765K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,799 |
9,592 |
$754K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
11,852 |
9,234 |
$732K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
49,846 |
41,914 |
$720K |
| 76825 |
|
3,186 |
2,502 |
$718K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
11,681 |
9,792 |
$709K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
34,227 |
29,585 |
$707K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
481 |
168 |
$704K |
| D7140 |
Extraction, erupted tooth or exposed root |
1,178 |
710 |
$659K |
| 99205 |
Prolong outpt/office vis |
7,172 |
6,024 |
$652K |
| 87536 |
|
12,607 |
10,703 |
$642K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17,018 |
14,329 |
$628K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12,404 |
10,448 |
$626K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
22,979 |
17,018 |
$611K |
| 99170 |
|
7,663 |
6,458 |
$609K |
| 49591 |
|
284 |
211 |
$589K |
| 94726 |
|
6,525 |
5,837 |
$589K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15,847 |
13,954 |
$582K |
| 72141 |
|
4,732 |
3,935 |
$577K |
| 93320 |
|
36,613 |
31,781 |
$576K |
| 73590 |
|
16,673 |
12,800 |
$572K |
| 77412 |
|
5,127 |
519 |
$570K |
| 72156 |
|
3,011 |
2,547 |
$568K |
| 88342 |
|
10,489 |
7,688 |
$567K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
33,754 |
26,601 |
$567K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
10,234 |
7,167 |
$567K |
| 76000 |
|
4,688 |
3,748 |
$566K |
| 96367 |
|
13,004 |
6,426 |
$566K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,792 |
3,932 |
$554K |
| 97161 |
|
11,042 |
9,371 |
$552K |
| 73562 |
|
18,651 |
15,057 |
$545K |
| 73610 |
|
16,472 |
13,378 |
$545K |
| 31720 |
|
4,788 |
3,025 |
$541K |
| 01922 |
|
5,252 |
4,659 |
$536K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
4,312 |
3,366 |
$536K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
117,766 |
97,670 |
$531K |
| 95782 |
|
871 |
761 |
$527K |
| 73630 |
|
15,470 |
12,562 |
$524K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
3,729 |
2,447 |
$523K |
| A0425 |
Ground mileage, per statute mile |
2,078 |
1,576 |
$518K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
4,051 |
3,590 |
$506K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
24,446 |
20,972 |
$504K |
| 72158 |
|
2,555 |
2,142 |
$497K |
| 93308 |
|
7,048 |
5,783 |
$496K |
| 77334 |
|
1,847 |
1,257 |
$495K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
74,355 |
56,683 |
$493K |
| 96415 |
|
8,834 |
6,022 |
$492K |
| 72157 |
|
2,553 |
2,144 |
$485K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
3,964 |
3,305 |
$483K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,061 |
795 |
$481K |
| 95816 |
|
5,359 |
4,699 |
$480K |
| 87070 |
|
53,563 |
44,001 |
$457K |
| J9310 |
Injection, rituximab, 100 mg |
176 |
110 |
$452K |
| 81025 |
|
55,030 |
44,310 |
$447K |
| 93325 |
|
61,168 |
51,336 |
$446K |
| 64493 |
|
1,069 |
930 |
$445K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
7,008 |
6,265 |
$445K |
| 74183 |
|
3,297 |
2,761 |
$439K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
58,452 |
50,850 |
$437K |
| 94728 |
|
6,468 |
5,672 |
$436K |
| 94150 |
|
3,950 |
2,181 |
$432K |
| 73090 |
|
11,654 |
8,770 |
$430K |
| 62323 |
|
1,587 |
1,398 |
$429K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
720 |
677 |
$425K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
11,004 |
3,798 |
$423K |
| 80061 |
Lipid panel |
41,713 |
36,255 |
$422K |
| 85027 |
|
86,769 |
63,624 |
$414K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
21,653 |
9,070 |
$414K |
| 76821 |
|
8,348 |
5,459 |
$405K |
| 83880 |
|
19,045 |
15,463 |
$402K |
| 73552 |
|
12,847 |
10,453 |
$402K |
| 81001 |
|
101,066 |
81,410 |
$399K |
| 59514 |
|
646 |
565 |
$393K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
8,236 |
7,372 |
$387K |
| 54640 |
|
197 |
146 |
$384K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
18,606 |
13,854 |
$384K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
8,840 |
7,377 |
$381K |
| 86003 |
|
8,056 |
3,970 |
$380K |
| 92579 |
|
4,375 |
3,970 |
$380K |
| 73130 |
|
9,479 |
7,399 |
$373K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
17,516 |
5,127 |
$366K |
| 97165 |
|
6,636 |
5,621 |
$365K |
| 73030 |
|
12,793 |
10,570 |
$355K |
| 77072 |
|
4,865 |
4,091 |
$355K |
| 67311 |
|
181 |
144 |
$350K |
| 70496 |
|
5,188 |
4,353 |
$347K |
| 86870 |
|
2,693 |
1,642 |
$346K |
| 70491 |
|
3,647 |
3,087 |
$342K |
| 77336 |
|
5,279 |
2,171 |
$341K |
| 43762 |
|
3,593 |
3,057 |
$341K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
4,747 |
3,475 |
$341K |
| 93451 |
|
511 |
333 |
$339K |
| 82728 |
|
35,219 |
27,265 |
$333K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
1,046 |
938 |
$329K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
28,166 |
24,923 |
$328K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16,858 |
14,899 |
$327K |
| 86360 |
|
11,675 |
9,942 |
$325K |
| 20610 |
|
6,266 |
5,156 |
$322K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,305 |
6,217 |
$322K |
| 77300 |
|
1,432 |
1,132 |
$320K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
6,391 |
4,343 |
$312K |
| 82803 |
|
22,472 |
17,524 |
$311K |
| S9110 |
Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month |
38,622 |
1,865 |
$311K |
| 95720 |
|
2,545 |
1,389 |
$311K |
| 59425 |
|
3,912 |
3,122 |
$304K |
| J1453 |
Injection, fosaprepitant, 1 mg |
2,337 |
1,341 |
$302K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
3,282 |
2,990 |
$300K |
| 92060 |
|
6,809 |
5,923 |
$299K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,065 |
3,837 |
$298K |
| 73110 |
|
7,485 |
5,792 |
$297K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,237 |
1,047 |
$297K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,336 |
3,792 |
$293K |
| 70498 |
|
4,868 |
4,079 |
$289K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,671 |
1,384 |
$287K |
| 92526 |
|
6,956 |
2,498 |
$284K |
| 73560 |
|
8,337 |
6,553 |
$284K |
| 88184 |
|
2,148 |
1,353 |
$282K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
43,415 |
36,278 |
$275K |
| 73080 |
|
6,758 |
5,204 |
$270K |
| 76536 |
|
5,481 |
4,740 |
$270K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13,967 |
12,340 |
$265K |
| 72100 |
|
5,832 |
5,060 |
$265K |
| 93017 |
|
2,853 |
2,522 |
$262K |
| 84439 |
|
33,425 |
28,423 |
$262K |
| 95811 |
|
544 |
495 |
$261K |
| 96417 |
|
6,415 |
3,772 |
$259K |
| 92523 |
|
2,095 |
1,773 |
$257K |
| 93976 |
|
6,286 |
5,166 |
$256K |
| 82947 |
|
90,920 |
50,266 |
$255K |
| 99242 |
|
4,701 |
4,085 |
$250K |
| 92567 |
|
13,535 |
11,983 |
$246K |
| 95700 |
|
2,051 |
1,763 |
$245K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
769 |
676 |
$243K |
| 19083 |
|
456 |
396 |
$242K |
| 99245 |
|
2,116 |
1,865 |
$241K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
2,810 |
2,730 |
$239K |
| 72197 |
|
1,198 |
1,007 |
$239K |
| 96523 |
|
9,039 |
6,378 |
$238K |
| 96130 |
|
2,953 |
2,630 |
$238K |
| 70486 |
|
4,026 |
3,264 |
$237K |
| 93970 |
|
5,946 |
4,949 |
$236K |
| 99220 |
|
2,205 |
1,931 |
$236K |
| 59426 |
|
2,657 |
1,742 |
$236K |
| 71250 |
|
5,726 |
4,978 |
$233K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
998 |
871 |
$232K |
| 73060 |
|
5,867 |
4,514 |
$231K |
| 99460 |
|
3,806 |
3,329 |
$231K |
| 82248 |
|
56,209 |
41,415 |
$230K |
| 93886 |
|
1,430 |
1,194 |
$228K |
| 92015 |
Determination of refractive state |
11,543 |
9,573 |
$228K |
| 73100 |
|
5,602 |
4,078 |
$227K |
| 99255 |
|
2,426 |
1,956 |
$226K |
| 83970 |
|
9,619 |
8,132 |
$226K |
| 86780 |
|
25,478 |
19,416 |
$221K |
| 73620 |
|
5,035 |
3,698 |
$220K |
| 72146 |
|
1,324 |
1,083 |
$219K |
| 43235 |
|
855 |
748 |
$219K |
| 76642 |
|
7,883 |
6,464 |
$218K |
| 74178 |
|
1,645 |
1,442 |
$213K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,094 |
2,824 |
$213K |
| 94762 |
|
3,209 |
1,961 |
$211K |
| 83605 |
|
29,246 |
20,979 |
$205K |
| 73070 |
|
4,550 |
3,480 |
$205K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,395 |
2,930 |
$204K |
| 70543 |
|
876 |
724 |
$204K |
| 72040 |
|
5,932 |
5,027 |
$203K |
| 73120 |
|
2,786 |
2,003 |
$202K |
| 92585 |
|
1,201 |
1,070 |
$201K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
3,149 |
2,497 |
$200K |
| 76827 |
|
3,594 |
2,732 |
$197K |
| 86832 |
|
1,369 |
1,042 |
$196K |
| 73502 |
|
7,445 |
6,317 |
$195K |
| 86833 |
|
1,369 |
1,042 |
$194K |
| 42821 |
|
108 |
80 |
$193K |
| 74019 |
|
3,489 |
2,859 |
$191K |
| 83735 |
|
47,816 |
30,789 |
$191K |
| 12011 |
|
1,596 |
1,279 |
$190K |
| 64643 |
|
7,905 |
6,737 |
$190K |
| 93225 |
|
2,286 |
1,975 |
$189K |
| 96409 |
|
1,627 |
1,120 |
$189K |
| 87563 |
|
8,295 |
5,540 |
$187K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
8,357 |
7,337 |
$186K |
| 74230 |
|
3,314 |
2,879 |
$185K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,727 |
2,362 |
$185K |
| 70250 |
|
3,011 |
2,462 |
$180K |
| 74022 |
|
4,728 |
3,727 |
$179K |
| 93975 |
|
1,538 |
1,241 |
$178K |
| 86235 |
|
4,829 |
2,382 |
$177K |
| 95819 |
|
2,034 |
1,759 |
$177K |
| 94060 |
|
1,301 |
1,129 |
$176K |
| 99201 |
|
8,519 |
7,646 |
$175K |
| 77066 |
Tomosynthesis, mammo |
3,512 |
2,980 |
$174K |
| 95911 |
|
729 |
613 |
$174K |
| 87077 |
|
23,674 |
17,272 |
$170K |
| 92652 |
|
1,180 |
985 |
$169K |
| 99462 |
|
5,656 |
4,053 |
$169K |
| J9070 |
Cyclophosphamide, 100 mg |
687 |
452 |
$168K |
| 85046 |
|
37,286 |
25,198 |
$167K |
| 76830 |
Ultrasound, transvaginal |
3,305 |
2,694 |
$166K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,690 |
2,181 |
$165K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
3,967 |
3,405 |
$164K |
| 31231 |
|
1,298 |
1,179 |
$163K |
| 80047 |
|
20,346 |
16,936 |
$163K |
| 99468 |
|
437 |
344 |
$159K |
| 99254 |
|
2,276 |
1,831 |
$157K |
| 73564 |
|
1,380 |
1,177 |
$156K |
| 86481 |
|
2,451 |
2,180 |
$156K |
| 44970 |
|
31 |
26 |
$156K |
| P9037 |
Platelets, pheresis, leukocytes reduced, irradiated, each unit |
464 |
222 |
$155K |
| 83021 |
|
12,100 |
8,364 |
$153K |
| 97162 |
|
3,888 |
3,320 |
$153K |
| 86140 |
|
36,707 |
29,610 |
$152K |
| 80074 |
|
4,752 |
3,850 |
$151K |
| 96401 |
|
4,772 |
2,381 |
$150K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
631 |
513 |
$148K |
| 80069 |
|
24,672 |
18,384 |
$147K |
| 92588 |
|
903 |
805 |
$147K |
| 99253 |
|
2,205 |
1,832 |
$146K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,942 |
1,563 |
$146K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
537 |
440 |
$145K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,260 |
3,022 |
$143K |
| 86480 |
|
3,491 |
2,838 |
$143K |
| 83655 |
|
12,662 |
11,293 |
$141K |
| 76506 |
|
5,636 |
4,687 |
$140K |
| 92582 |
|
1,692 |
1,426 |
$140K |
| 93880 |
|
2,148 |
1,896 |
$139K |
| 85610 |
|
49,654 |
36,993 |
$139K |
| 97116 |
|
11,097 |
4,446 |
$138K |
| 76801 |
|
2,194 |
1,762 |
$138K |
| 96131 |
|
2,166 |
1,911 |
$137K |
| 77065 |
Tomosynthesis, mammo |
3,266 |
2,766 |
$137K |
| 88304 |
|
6,022 |
4,753 |
$134K |
| 74240 |
|
1,588 |
1,413 |
$134K |
| 10060 |
|
1,047 |
881 |
$133K |
| 72070 |
|
2,401 |
1,975 |
$129K |
| 49083 |
|
427 |
210 |
$128K |
| 82784 |
|
15,710 |
9,162 |
$128K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
433 |
320 |
$127K |
| 93321 |
|
18,095 |
14,649 |
$125K |
| 86077 |
|
4,723 |
3,922 |
$123K |
| 49650 |
|
43 |
37 |
$122K |
| 99222 |
Initial hospital care, per day, moderate complexity |
3,276 |
2,600 |
$122K |
| 69210 |
|
3,539 |
3,044 |
$122K |
| 72190 |
|
2,132 |
1,783 |
$121K |
| 31575 |
|
2,085 |
1,823 |
$120K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
43,489 |
36,775 |
$120K |
| 84403 |
|
5,396 |
4,587 |
$117K |
| 92597 |
|
1,863 |
1,515 |
$116K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,150 |
2,370 |
$116K |
| 93971 |
|
4,160 |
3,679 |
$115K |
| 87040 |
|
14,664 |
10,040 |
$115K |
| 84484 |
|
13,926 |
9,256 |
$115K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,688 |
2,054 |
$115K |
| 84702 |
|
10,967 |
7,614 |
$115K |
| 74455 |
|
1,002 |
885 |
$115K |
| 82570 |
|
28,546 |
21,898 |
$113K |
| 59025 |
Fetal non-stress test |
3,105 |
2,571 |
$112K |
| 78816 |
|
211 |
175 |
$111K |
| 97166 |
|
2,619 |
2,157 |
$110K |
| 93922 |
|
3,745 |
3,329 |
$109K |
| 87186 |
|
16,602 |
12,856 |
$109K |
| 96101 |
|
1,039 |
868 |
$109K |
| 81003 |
|
50,093 |
39,423 |
$108K |
| 86160 |
|
14,779 |
6,331 |
$107K |
| 01961 |
|
431 |
395 |
$107K |
| 84100 |
|
37,614 |
25,527 |
$106K |
| 80197 |
|
13,988 |
8,694 |
$103K |
| 95813 |
|
714 |
605 |
$103K |
| 95115 |
|
3,382 |
1,591 |
$103K |
| 74170 |
|
1,179 |
1,061 |
$103K |
| 85730 |
|
24,792 |
19,786 |
$102K |
| 82607 |
|
10,513 |
9,155 |
$101K |
| 69631 |
|
33 |
24 |
$101K |
| 93296 |
|
7,716 |
7,041 |
$100K |
| 88185 |
|
2,547 |
1,323 |
$99K |
| 12001 |
|
924 |
740 |
$99K |
| 36556 |
|
248 |
168 |
$99K |
| 78306 |
|
853 |
781 |
$99K |
| 77301 |
|
191 |
152 |
$97K |
| 76870 |
|
1,405 |
1,142 |
$97K |
| 77295 |
|
142 |
121 |
$97K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,219 |
8,248 |
$97K |
| 75625 |
|
150 |
136 |
$96K |
| 73600 |
|
1,842 |
1,338 |
$96K |
| 72110 |
|
1,749 |
1,552 |
$96K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
8,262 |
7,354 |
$96K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
614 |
463 |
$95K |
| 17110 |
|
1,363 |
1,141 |
$94K |
| 80076 |
|
14,559 |
12,391 |
$92K |
| 88300 |
|
8,243 |
6,781 |
$92K |
| T1017 |
Targeted case management, each 15 minutes |
2,008 |
801 |
$91K |
| 43760 |
|
701 |
608 |
$91K |
| 83550 |
|
15,923 |
13,559 |
$90K |
| 64450 |
|
346 |
284 |
$90K |
| 82330 |
|
10,008 |
6,986 |
$89K |
| 95874 |
|
10,359 |
8,815 |
$87K |
| 92134 |
|
7,958 |
7,390 |
$87K |
| 11043 |
|
537 |
367 |
$87K |
| 87497 |
|
5,404 |
3,582 |
$85K |
| 83516 |
|
5,884 |
4,437 |
$85K |
| 96411 |
|
1,481 |
983 |
$85K |
| 94664 |
|
4,843 |
4,265 |
$85K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
89 |
39 |
$84K |
| 51701 |
|
1,307 |
1,137 |
$84K |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
66 |
41 |
$84K |
| 76885 |
|
1,544 |
1,368 |
$82K |
| 29450 |
|
619 |
291 |
$81K |
| 93000 |
|
6,499 |
6,157 |
$80K |
| 90670 |
|
21,984 |
20,291 |
$80K |
| 83615 |
|
18,527 |
13,384 |
$80K |
| 87807 |
|
7,558 |
6,541 |
$79K |
| 37225 |
|
56 |
51 |
$78K |
| 97533 |
|
2,498 |
896 |
$78K |
| 87522 |
Neg quan hep c or qual rna |
2,735 |
2,424 |
$77K |
| 73700 |
|
1,188 |
920 |
$75K |
| 49593 |
|
33 |
24 |
$75K |
| 90686 |
|
28,355 |
24,147 |
$75K |
| 93798 |
|
3,039 |
531 |
$74K |
| 83540 |
|
17,304 |
14,482 |
$73K |
| 83002 |
|
4,375 |
3,666 |
$73K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
5,961 |
5,173 |
$73K |
| 77470 |
|
286 |
252 |
$72K |
| 82533 |
|
5,202 |
3,709 |
$72K |
| 73000 |
|
1,398 |
1,023 |
$71K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,561 |
1,452 |
$71K |
| 12002 |
|
519 |
380 |
$71K |
| 84156 |
|
25,797 |
20,730 |
$70K |
| 82785 |
|
5,715 |
4,222 |
$70K |
| 83520 |
|
5,075 |
4,098 |
$69K |
| 29125 |
|
954 |
801 |
$69K |
| 82550 |
|
12,291 |
9,686 |
$68K |
| 83001 |
|
4,288 |
3,591 |
$68K |
| 88173 |
|
2,426 |
1,438 |
$67K |
| 96137 |
|
1,574 |
1,409 |
$67K |
| 82670 |
|
2,816 |
2,283 |
$67K |
| 94250 |
|
1,398 |
1,180 |
$66K |
| 85660 |
|
18,894 |
7,065 |
$66K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
34 |
16 |
$65K |
| 86147 |
|
1,253 |
998 |
$65K |
| 84402 |
|
2,761 |
2,410 |
$65K |
| 85652 |
|
30,243 |
25,097 |
$65K |
| 96450 |
|
475 |
300 |
$65K |
| 88141 |
|
4,375 |
3,969 |
$64K |
| 85007 |
|
21,383 |
14,109 |
$64K |
| 92551 |
|
9,819 |
7,987 |
$64K |
| P9011 |
Blood, split unit |
836 |
568 |
$64K |
| 62270 |
|
224 |
191 |
$64K |
| 87340 |
|
9,783 |
8,199 |
$63K |
| 87906 |
|
925 |
811 |
$62K |
| J2182 |
Injection, mepolizumab, 1 mg |
37 |
37 |
$61K |
| 72050 |
|
1,072 |
890 |
$61K |
| 86803 |
|
6,972 |
5,983 |
$61K |
| 88108 |
|
4,518 |
3,153 |
$60K |
| 84305 |
|
3,309 |
2,831 |
$59K |
| 92611 |
|
1,160 |
1,009 |
$59K |
| 88313 |
|
2,453 |
1,450 |
$59K |
| 99442 |
|
2,411 |
2,051 |
$59K |
| 77014 |
|
2,206 |
339 |
$58K |
| 83690 |
|
12,724 |
10,261 |
$58K |
| 77290 |
|
297 |
230 |
$58K |
| 36591 |
|
13,109 |
8,622 |
$58K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,101 |
1,023 |
$57K |
| 95715 |
|
244 |
131 |
$57K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
337 |
199 |
$57K |
| 74220 |
|
540 |
469 |
$56K |
| 96136 |
|
1,927 |
1,702 |
$55K |
| 82375 |
|
7,441 |
5,064 |
$54K |
| 86038 |
|
5,685 |
4,651 |
$54K |
| 82043 |
|
13,069 |
11,512 |
$54K |
| 88341 |
|
6,473 |
3,329 |
$53K |
| 84153 |
|
4,718 |
4,027 |
$53K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
2,816 |
1,409 |
$53K |
| 70544 |
|
465 |
354 |
$53K |
| 31624 |
|
183 |
119 |
$52K |
| 86317 |
|
1,598 |
785 |
$52K |
| 87799 |
|
4,870 |
2,965 |
$52K |
| 82105 |
|
4,712 |
3,984 |
$52K |
| 99471 |
|
115 |
87 |
$51K |
| 99217 |
|
1,223 |
1,075 |
$51K |
| 73522 |
|
1,025 |
883 |
$51K |
| 73221 |
|
447 |
379 |
$50K |
| 86376 |
|
3,977 |
3,382 |
$50K |
| 82746 |
|
5,380 |
4,636 |
$49K |
| 95117 |
|
1,828 |
811 |
$49K |
| 72131 |
|
972 |
789 |
$49K |
| 62370 |
|
551 |
470 |
$49K |
| 80177 |
|
4,563 |
3,824 |
$49K |
| 88312 |
|
2,004 |
1,023 |
$49K |
| 84550 |
|
14,804 |
11,209 |
$48K |
| 90732 |
|
980 |
792 |
$48K |
| 77075 |
|
767 |
654 |
$48K |
| 78708 |
|
221 |
196 |
$48K |
| 82610 |
|
3,944 |
3,250 |
$48K |
| 93295 |
|
2,984 |
2,837 |
$48K |
| 75561 |
|
235 |
187 |
$47K |
| 86762 |
|
4,923 |
3,971 |
$47K |
| 99221 |
|
1,159 |
950 |
$47K |
| 82810 |
|
7,699 |
5,235 |
$47K |
| 87205 |
|
13,920 |
10,831 |
$46K |
| 84146 |
|
2,788 |
2,391 |
$46K |
| 86225 |
|
4,783 |
3,725 |
$45K |
| 86880 |
|
1,825 |
776 |
$45K |
| 97542 |
|
1,618 |
1,208 |
$45K |
| 82565 |
|
13,444 |
11,722 |
$44K |
| 92553 |
|
804 |
665 |
$44K |
| 31622 |
|
105 |
78 |
$44K |
| 83498 |
|
1,771 |
1,511 |
$43K |
| 96161 |
|
9,637 |
8,800 |
$43K |
| 86592 |
|
12,115 |
10,344 |
$42K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
51 |
38 |
$42K |
| 82627 |
|
2,051 |
1,759 |
$42K |
| 90734 |
|
2,044 |
1,637 |
$42K |
| 82024 |
|
1,374 |
1,141 |
$41K |
| 96402 |
|
1,164 |
961 |
$41K |
| 92557 |
|
673 |
593 |
$41K |
| 93923 |
|
993 |
910 |
$41K |
| 85018 |
|
22,082 |
15,295 |
$41K |
| 71271 |
|
1,015 |
824 |
$41K |
| 99443 |
|
1,024 |
903 |
$41K |
| L8613 |
Ossicula implant |
1,225 |
1,065 |
$41K |
| J9267 |
Injection, paclitaxel, 1 mg |
2,566 |
1,382 |
$40K |
| 99173 |
|
14,465 |
12,113 |
$39K |
| 93531 |
|
47 |
39 |
$39K |
| 87507 |
|
143 |
117 |
$39K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
722 |
590 |
$39K |
| 36561 |
|
27 |
26 |
$38K |
| 83883 |
|
2,887 |
2,256 |
$38K |
| 76937 |
|
15,583 |
12,067 |
$38K |
| 82378 |
|
2,881 |
2,231 |
$37K |
| A0225 |
Ambulance service, neonatal transport, base rate, emergency transport, one way |
196 |
152 |
$37K |
| 86706 |
|
5,126 |
4,399 |
$37K |
| J9045 |
Injection, carboplatin, 50 mg |
3,057 |
1,763 |
$36K |
| 84165 |
|
5,807 |
4,919 |
$36K |
| 51600 |
|
1,225 |
1,082 |
$36K |
| 77338 |
|
268 |
205 |
$36K |
| 90461 |
|
17,330 |
16,526 |
$36K |
| 90750 |
|
497 |
406 |
$35K |
| 00126 |
|
620 |
566 |
$35K |
| 74174 |
|
293 |
254 |
$35K |
| P9041 |
Infusion, albumin (human), 5%, 50 ml |
514 |
331 |
$35K |
| 93458 |
|
31 |
26 |
$35K |
| 86704 |
|
4,495 |
3,863 |
$35K |
| 83050 |
|
7,588 |
5,039 |
$34K |
| 82977 |
|
6,481 |
4,950 |
$34K |
| 73720 |
|
143 |
113 |
$34K |
| 75710 |
|
74 |
69 |
$34K |
| 54360 |
|
15 |
14 |
$33K |
| 86039 |
|
3,838 |
3,042 |
$32K |
| 90961 |
|
475 |
455 |
$32K |
| 85045 |
|
11,390 |
8,786 |
$32K |
| 99381 |
|
666 |
602 |
$32K |
| 84132 |
|
12,533 |
8,947 |
$31K |
| 64635 |
|
41 |
39 |
$31K |
| 87517 |
|
1,374 |
1,202 |
$31K |
| 93282 |
|
1,927 |
1,664 |
$31K |
| 21235 |
|
12 |
12 |
$30K |
| 76604 |
|
691 |
526 |
$30K |
| 76857 |
|
553 |
411 |
$30K |
| 54300 |
|
15 |
12 |
$30K |
| 93297 |
|
2,890 |
2,648 |
$30K |
| 86255 |
|
2,031 |
1,476 |
$29K |
| 96373 |
|
418 |
326 |
$28K |
| 81373 |
|
606 |
424 |
$28K |
| 80164 |
|
2,739 |
2,316 |
$28K |
| 49500 |
|
18 |
14 |
$28K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
51 |
41 |
$28K |
| 87102 |
|
4,441 |
3,393 |
$28K |
| J9041 |
Injection, bortezomib, 0.1 mg |
136 |
39 |
$28K |
| 27096 |
|
362 |
321 |
$28K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
181 |
155 |
$28K |
| 86146 |
|
690 |
536 |
$28K |
| 62328 |
|
110 |
77 |
$28K |
| 74270 |
|
311 |
260 |
$27K |
| 85014 |
|
18,856 |
15,159 |
$27K |
| 93280 |
|
1,870 |
1,654 |
$27K |
| 72120 |
|
423 |
339 |
$27K |
| 80143 |
|
1,873 |
1,514 |
$27K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
3,346 |
2,592 |
$27K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
22,372 |
19,618 |
$27K |
| 87535 |
|
1,005 |
820 |
$26K |
| 90651 |
|
2,335 |
1,653 |
$26K |
| 92610 |
|
667 |
548 |
$26K |
| 86787 |
|
3,012 |
2,135 |
$26K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
433 |
406 |
$26K |
| 87045 |
|
2,543 |
2,103 |
$26K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,772 |
4,037 |
$26K |
| 95822 |
|
968 |
759 |
$25K |
| 86800 |
|
1,970 |
1,651 |
$25K |
| 77427 |
|
997 |
511 |
$25K |
| 86665 |
|
1,616 |
864 |
$25K |
| 84295 |
|
10,422 |
7,193 |
$24K |
| 70480 |
|
358 |
280 |
$24K |
| 76882 |
|
340 |
274 |
$24K |
| 87081 |
|
5,606 |
4,663 |
$24K |
| 76377 |
|
1,178 |
997 |
$24K |
| 99235 |
|
242 |
184 |
$24K |
| 82139 |
|
1,702 |
1,416 |
$24K |
| 00920 |
|
353 |
302 |
$23K |
| 83519 |
|
1,481 |
1,047 |
$23K |
| 80179 |
|
1,640 |
1,369 |
$23K |
| 87075 |
|
3,456 |
2,535 |
$23K |
| 93298 |
|
1,642 |
1,506 |
$23K |
| 99219 |
|
315 |
271 |
$23K |
| 86304 |
|
1,762 |
1,399 |
$22K |
| 27606 |
|
15 |
13 |
$22K |
| 83525 |
|
2,116 |
1,780 |
$22K |
| 86200 |
|
2,416 |
1,833 |
$22K |
| A4565 |
Slings |
1,462 |
1,200 |
$21K |
| 82820 |
|
3,325 |
1,795 |
$21K |
| 81243 |
|
1,340 |
1,125 |
$21K |
| 01920 |
|
126 |
108 |
$21K |
| 64615 |
|
172 |
132 |
$20K |
| 84681 |
|
1,269 |
1,021 |
$20K |
| 72128 |
|
358 |
309 |
$20K |
| 86790 |
|
2,308 |
1,955 |
$20K |
| 85379 |
|
2,519 |
2,141 |
$19K |
| 87046 |
|
2,540 |
2,100 |
$19K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
495 |
277 |
$19K |
| 77370 |
|
309 |
268 |
$19K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
24 |
12 |
$19K |
| C1769 |
Guide wire |
9,896 |
7,406 |
$19K |
| 86355 |
|
675 |
498 |
$18K |
| 69200 |
|
384 |
282 |
$18K |
| 95886 |
|
2,212 |
1,942 |
$18K |
| 87486 |
|
634 |
516 |
$18K |
| 29580 |
|
263 |
94 |
$18K |
| 87581 |
|
634 |
516 |
$18K |
| 93356 |
|
1,478 |
1,162 |
$18K |
| 77280 |
|
215 |
164 |
$17K |
| 87210 |
|
5,420 |
4,180 |
$17K |
| 92555 |
|
2,522 |
2,192 |
$17K |
| 86359 |
|
605 |
449 |
$17K |
| 78803 |
|
72 |
65 |
$17K |
| 73140 |
|
330 |
260 |
$16K |
| 85060 |
|
1,473 |
1,097 |
$16K |
| 84134 |
|
1,759 |
1,485 |
$16K |
| 88172 |
|
206 |
161 |
$16K |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
60 |
27 |
$16K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,200 |
6,047 |
$16K |
| 86334 |
|
1,664 |
1,487 |
$16K |
| 86431 |
|
3,567 |
2,993 |
$15K |
| 82340 |
|
2,564 |
2,123 |
$15K |
| 92504 |
|
840 |
751 |
$15K |
| 93242 |
|
725 |
652 |
$15K |
| 93283 |
|
962 |
858 |
$15K |
| 86301 |
|
1,066 |
822 |
$15K |
| 82247 |
|
3,600 |
2,448 |
$15K |
| 99441 |
|
944 |
777 |
$15K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,928 |
1,631 |
$15K |
| 19081 |
|
26 |
25 |
$15K |
| 99051 |
|
1,352 |
1,167 |
$15K |
| 82379 |
|
985 |
818 |
$14K |
| 00731 |
|
550 |
465 |
$14K |
| 95910 |
|
103 |
89 |
$14K |
| 11044 |
|
45 |
24 |
$14K |
| 80235 |
|
815 |
684 |
$14K |
| 70546 |
|
79 |
66 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
63,833 |
43,489 |
$14K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
50,597 |
35,974 |
$14K |
| 82140 |
|
1,336 |
977 |
$14K |
| 88311 |
|
3,066 |
2,310 |
$14K |
| 77076 |
|
223 |
171 |
$14K |
| 92133 |
|
1,561 |
1,239 |
$13K |
| 82435 |
|
5,330 |
4,134 |
$13K |
| 87899 |
|
1,724 |
572 |
$13K |
| 85097 |
|
129 |
95 |
$13K |
| 84480 |
|
1,135 |
992 |
$13K |
| 84244 |
|
783 |
609 |
$13K |
| 95885 |
|
1,083 |
935 |
$13K |
| 87116 |
|
1,758 |
1,309 |
$13K |
| 95251 |
|
1,000 |
897 |
$13K |
| 86696 |
|
941 |
767 |
$13K |
| 85384 |
|
1,949 |
1,352 |
$13K |
| 76080 |
|
65 |
52 |
$13K |
| 85347 |
|
3,660 |
1,774 |
$12K |
| J0178 |
Injection, aflibercept, 1 mg |
17 |
16 |
$12K |
| C1776 |
Joint device (implantable) |
423 |
341 |
$12K |
| 86357 |
|
457 |
332 |
$12K |
| 84446 |
|
1,160 |
990 |
$12K |
| 82150 |
|
2,677 |
2,064 |
$12K |
| 94729 |
|
5,380 |
4,865 |
$12K |
| 76981 |
|
1,911 |
1,582 |
$12K |
| 58100 |
|
201 |
152 |
$12K |
| 95713 |
|
48 |
41 |
$12K |
| 25605 |
|
17 |
14 |
$12K |
| 90620 |
|
348 |
268 |
$12K |
| J9370 |
Vincristine sulfate, 1 mg |
3,367 |
2,010 |
$12K |
| 76775 |
|
263 |
224 |
$12K |
| 81404 |
|
647 |
483 |
$12K |
| 36593 |
|
99 |
62 |
$11K |
| 84450 |
|
2,690 |
2,172 |
$11K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
386 |
201 |
$11K |
| 85613 |
|
929 |
690 |
$11K |
| 95909 |
|
93 |
87 |
$11K |
| J3489 |
Injection, zoledronic acid, 1 mg |
803 |
689 |
$11K |
| 92604 |
|
174 |
154 |
$11K |
| 89051 |
|
2,838 |
2,026 |
$11K |
| 90962 |
|
245 |
222 |
$11K |
| 94642 |
|
115 |
91 |
$10K |
| 85397 |
|
421 |
356 |
$10K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
697 |
574 |
$10K |
| 84238 |
|
504 |
425 |
$10K |
| 82085 |
|
1,340 |
1,049 |
$10K |
| 83935 |
|
1,801 |
1,442 |
$10K |
| 36000 |
|
4,913 |
4,035 |
$10K |
| 83010 |
|
1,263 |
954 |
$10K |
| 00790 |
|
95 |
85 |
$10K |
| 69209 |
|
261 |
236 |
$10K |
| C1760 |
Closure device, vascular (implantable/insertable) |
3,029 |
2,410 |
$10K |
| V5020 |
Conformity evaluation |
1,468 |
1,211 |
$10K |
| 82088 |
|
351 |
268 |
$10K |
| 51798 |
|
1,621 |
1,524 |
$10K |
| 82157 |
|
389 |
332 |
$10K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
425 |
365 |
$10K |
| 82542 |
|
500 |
412 |
$9K |
| 38222 |
|
15 |
14 |
$9K |
| 90674 |
|
1,734 |
933 |
$9K |
| 92552 |
|
1,021 |
919 |
$9K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
356 |
222 |
$9K |
| 86695 |
|
938 |
767 |
$9K |
| 87430 |
|
401 |
389 |
$9K |
| 99252 |
|
231 |
189 |
$9K |
| 80306 |
|
699 |
582 |
$9K |
| 86644 |
|
821 |
650 |
$9K |
| 80183 |
|
804 |
681 |
$9K |
| 99236 |
Prolong inpt eval add15 m |
69 |
53 |
$9K |
| 99152 |
|
7,035 |
6,219 |
$8K |
| 99457 |
|
1,111 |
1,084 |
$8K |
| 93312 |
|
56 |
43 |
$8K |
| 80203 |
|
831 |
717 |
$8K |
| 85240 |
|
566 |
461 |
$8K |
| 84590 |
|
1,006 |
859 |
$8K |
| 93284 |
|
771 |
649 |
$8K |
| 64644 |
|
43 |
38 |
$8K |
| 50435 |
|
12 |
12 |
$8K |
| 77012 |
|
770 |
639 |
$8K |
| 72081 |
|
768 |
703 |
$8K |
| 99383 |
|
155 |
127 |
$8K |
| 85246 |
|
410 |
346 |
$8K |
| 99382 |
|
173 |
153 |
$8K |
| D7210 |
Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth |
13 |
12 |
$8K |
| 84445 |
|
200 |
166 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
480 |
328 |
$8K |
| 0071A |
|
362 |
339 |
$8K |
| 90715 |
|
3,806 |
3,106 |
$7K |
| 96160 |
|
3,745 |
3,031 |
$7K |
| 83789 |
|
387 |
318 |
$7K |
| 29105 |
|
99 |
77 |
$7K |
| 93246 |
|
325 |
286 |
$7K |
| 84425 |
|
609 |
530 |
$7K |
| 88189 |
|
137 |
113 |
$7K |
| 88346 |
|
90 |
56 |
$7K |
| 99417 |
Prolong home eval add 15m |
1,141 |
990 |
$7K |
| 84478 |
|
1,124 |
940 |
$7K |
| 86063 |
|
1,427 |
1,123 |
$7K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,561 |
1,427 |
$7K |
| 11981 |
|
91 |
81 |
$6K |
| 94618 |
|
147 |
126 |
$6K |
| 87902 |
|
34 |
25 |
$6K |
| 81406 |
|
893 |
627 |
$6K |
| 82951 |
|
683 |
564 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
65,055 |
49,658 |
$6K |
| 82657 |
|
368 |
291 |
$6K |
| 85732 |
|
1,221 |
752 |
$6K |
| 11900 |
|
211 |
187 |
$6K |
| 94070 |
|
50 |
27 |
$6K |
| 87206 |
|
1,621 |
1,215 |
$6K |
| 80195 |
|
697 |
398 |
$6K |
| 92083 |
|
346 |
224 |
$5K |
| 86215 |
|
398 |
319 |
$5K |
| 86777 |
|
595 |
473 |
$5K |
| 12013 |
|
56 |
48 |
$5K |
| 49465 |
|
70 |
65 |
$5K |
| 99454 |
|
800 |
788 |
$5K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
26,581 |
18,808 |
$5K |
| 00840 |
|
107 |
89 |
$5K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
46 |
27 |
$5K |
| 82164 |
|
472 |
400 |
$5K |
| 92081 |
|
139 |
117 |
$5K |
| D2940 |
|
109 |
96 |
$5K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
241 |
116 |
$5K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
95 |
81 |
$5K |
| 64405 |
|
48 |
46 |
$5K |
| 0072A |
|
295 |
275 |
$5K |
| 82652 |
|
213 |
191 |
$5K |
| 84460 |
|
997 |
863 |
$5K |
| 31500 |
|
100 |
66 |
$5K |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
2,537 |
1,950 |
$5K |
| 80299 |
|
385 |
318 |
$5K |
| 94010 |
|
637 |
575 |
$5K |
| 85651 |
|
1,603 |
1,365 |
$5K |
| 82017 |
|
337 |
299 |
$5K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
2,145 |
1,675 |
$4K |
| D1120 |
Prophylaxis - child |
104 |
90 |
$4K |
| 70360 |
|
122 |
83 |
$4K |
| 84166 |
|
567 |
517 |
$4K |
| 0296T |
|
410 |
355 |
$4K |
| 93299 |
|
249 |
241 |
$4K |
| 36620 |
|
473 |
359 |
$4K |
| 87420 |
|
299 |
287 |
$4K |
| 99464 |
|
304 |
260 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
3,776 |
3,009 |
$4K |
| 00400 |
|
72 |
57 |
$4K |
| 99354 |
|
56 |
52 |
$4K |
| 83919 |
|
247 |
211 |
$4K |
| 81405 |
|
714 |
528 |
$4K |
| 86860 |
|
44 |
37 |
$4K |
| 78264 |
|
39 |
38 |
$4K |
| 92595 |
|
934 |
794 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,689 |
1,698 |
$4K |
| 77080 |
|
252 |
243 |
$4K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
337 |
273 |
$4K |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
773 |
618 |
$4K |
| A9562 |
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries |
142 |
120 |
$4K |
| 82731 |
|
74 |
58 |
$4K |
| 82390 |
|
463 |
387 |
$4K |
| 99490 |
Ccm add 20min |
1,030 |
881 |
$4K |
| 96377 |
|
238 |
174 |
$4K |
| 99384 |
|
96 |
70 |
$4K |
| 54162 |
|
25 |
24 |
$4K |
| 97014 |
|
470 |
192 |
$4K |
| 90746 |
|
92 |
86 |
$4K |
| 84210 |
|
337 |
285 |
$4K |
| L4386 |
Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
562 |
469 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
12,027 |
8,117 |
$4K |
| 96910 |
|
84 |
29 |
$4K |
| 84157 |
|
1,225 |
976 |
$4K |
| 99465 |
|
86 |
70 |
$4K |
| 86337 |
|
220 |
199 |
$4K |
| 72192 |
|
123 |
77 |
$4K |
| 99358 |
Prolong nursin fac eval 15m |
146 |
139 |
$4K |
| 11100 |
|
71 |
65 |
$4K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
52 |
42 |
$4K |
| V5264 |
Ear mold/insert, not disposable, any type |
1,381 |
1,110 |
$4K |
| 29065 |
|
68 |
54 |
$4K |
| 99477 |
|
15 |
12 |
$4K |
| 86162 |
|
348 |
223 |
$4K |
| 82310 |
|
1,190 |
936 |
$4K |
| 62322 |
|
111 |
94 |
$4K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
2,284 |
1,976 |
$4K |
| 36416 |
|
27,199 |
22,609 |
$4K |
| 86593 |
|
1,268 |
1,025 |
$3K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
13 |
12 |
$3K |
| 82945 |
|
1,053 |
850 |
$3K |
| 17250 |
|
65 |
56 |
$3K |
| 90656 |
|
1,214 |
1,188 |
$3K |
| 90945 |
|
134 |
41 |
$3K |
| 11982 |
|
13 |
12 |
$3K |
| 88333 |
|
19 |
15 |
$3K |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
2,273 |
1,515 |
$3K |
| 83835 |
|
237 |
188 |
$3K |
| 95712 |
|
16 |
13 |
$3K |
| 31615 |
|
28 |
26 |
$3K |
| 29075 |
|
49 |
44 |
$3K |
| 00300 |
|
49 |
36 |
$3K |
| 73521 |
|
44 |
39 |
$3K |
| 91040 |
|
46 |
26 |
$3K |
| 84481 |
|
230 |
159 |
$3K |
| 84207 |
|
158 |
139 |
$3K |
| 80175 |
|
317 |
272 |
$3K |
| 77263 |
|
28 |
28 |
$3K |
| 97016 |
|
152 |
57 |
$3K |
| 88331 |
|
69 |
51 |
$3K |
| 96376 |
|
5,292 |
4,264 |
$3K |
| 96368 |
|
1,323 |
785 |
$3K |
| 76818 |
|
59 |
41 |
$3K |
| 10005 |
|
13 |
13 |
$3K |
| 80185 |
|
258 |
224 |
$3K |
| 90710 |
|
1,349 |
1,135 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
5,684 |
4,327 |
$3K |
| 90966 |
|
75 |
69 |
$3K |
| 88302 |
|
395 |
282 |
$3K |
| 76942 |
|
2,474 |
2,017 |
$3K |
| 29581 |
|
64 |
24 |
$3K |
| 01968 |
|
46 |
42 |
$3K |
| 95990 |
|
13 |
12 |
$3K |
| 20552 |
|
15 |
14 |
$2K |
| 77001 |
|
1,022 |
860 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
310 |
300 |
$2K |
| 90870 |
|
33 |
12 |
$2K |
| 80201 |
|
228 |
195 |
$2K |
| Q4036 |
Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass |
99 |
43 |
$2K |
| 82016 |
|
278 |
197 |
$2K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
287 |
183 |
$2K |
| C9447 |
Injection, phenylephrine and ketorolac, 4 ml vial |
21 |
18 |
$2K |
| 81407 |
|
418 |
348 |
$2K |
| 88142 |
|
522 |
502 |
$2K |
| 11104 |
|
53 |
29 |
$2K |
| 82172 |
|
158 |
140 |
$2K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
64 |
40 |
$2K |
| 96132 |
|
45 |
44 |
$2K |
| 84155 |
|
2,029 |
1,531 |
$2K |
| 77002 |
|
1,578 |
1,353 |
$2K |
| 86364 |
|
707 |
562 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
4,709 |
4,159 |
$2K |
| 93285 |
|
116 |
110 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
1,945 |
774 |
$2K |
| 93271 |
|
33 |
21 |
$2K |
| 41010 |
|
24 |
24 |
$2K |
| 17311 |
|
14 |
12 |
$2K |
| 96133 |
|
25 |
25 |
$2K |
| A6021 |
Collagen dressing, sterile, size 16 sq. in. or less, each |
1,431 |
933 |
$2K |
| 51702 |
|
32 |
29 |
$2K |
| 87338 |
|
157 |
144 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
34,533 |
23,331 |
$2K |
| 75630 |
|
118 |
111 |
$2K |
| 81050 |
|
692 |
612 |
$2K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
53 |
41 |
$2K |
| 86308 |
|
408 |
337 |
$2K |
| 86684 |
|
182 |
92 |
$2K |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
1,112 |
859 |
$2K |
| 87493 |
|
66 |
55 |
$2K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
108 |
85 |
$2K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
2,182 |
1,688 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,116 |
6,466 |
$2K |
| 75635 |
|
16 |
13 |
$2K |
| 99475 |
|
14 |
12 |
$2K |
| 90785 |
|
274 |
170 |
$2K |
| 00750 |
|
13 |
12 |
$2K |
| 81380 |
|
50 |
45 |
$2K |
| 00320 |
|
25 |
18 |
$2K |
| 81403 |
|
200 |
180 |
$2K |
| L4360 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
75 |
71 |
$2K |
| 93227 |
|
92 |
81 |
$2K |
| J7999 |
Compounded drug, not otherwise classified |
187 |
170 |
$1K |
| 31579 |
|
44 |
38 |
$1K |
| 77332 |
|
19 |
12 |
$1K |
| 86711 |
|
276 |
218 |
$1K |
| 90633 |
|
7,368 |
6,621 |
$1K |
| 93294 |
|
152 |
151 |
$1K |
| 88112 |
|
150 |
100 |
$1K |
| 00140 |
|
48 |
31 |
$1K |
| 83993 |
|
95 |
77 |
$1K |
| 81332 |
|
94 |
79 |
$1K |
| L8509 |
Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type |
777 |
694 |
$1K |
| 90696 |
|
1,136 |
950 |
$1K |
| 82103 |
|
99 |
85 |
$1K |
| 83930 |
|
324 |
230 |
$1K |
| 52000 |
|
15 |
14 |
$1K |
| 70487 |
|
18 |
12 |
$1K |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
403 |
350 |
$1K |
| 94617 |
|
20 |
12 |
$1K |
| 92626 |
|
30 |
25 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
3,639 |
1,220 |
$1K |
| 64400 |
|
13 |
13 |
$1K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
286 |
180 |
$1K |
| 99306 |
Prolong nursin fac eval 15m |
12 |
12 |
$1K |
| 87449 |
|
207 |
101 |
$1K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
6,694 |
4,928 |
$1K |
| 00160 |
|
16 |
13 |
$1K |
| 86677 |
|
86 |
69 |
$1K |
| J9171 |
Injection, docetaxel, 1 mg |
17 |
14 |
$1K |
| 83921 |
|
81 |
76 |
$1K |
| 93793 |
|
538 |
386 |
$1K |
| 84466 |
|
151 |
121 |
$1K |
| V5010 |
Assessment for hearing aid |
310 |
276 |
$1K |
| 83521 |
|
1,362 |
1,045 |
$1K |
| 93279 |
|
43 |
39 |
$1K |
| 82010 |
|
204 |
166 |
$1K |
| V5140 |
Binaural, behind the ear |
21 |
14 |
$1K |
| 90756 |
|
78 |
76 |
$1K |
| 86060 |
|
130 |
111 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,062 |
1,439 |
$1K |
| 81002 |
|
443 |
371 |
$1K |
| 92082 |
|
78 |
55 |
$1K |
| 96112 |
|
21 |
12 |
$1K |
| 76828 |
|
18 |
14 |
$1K |
| 85670 |
|
264 |
212 |
$1K |
| 82465 |
|
308 |
272 |
$1K |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
94 |
92 |
$1K |
| 73660 |
|
22 |
15 |
$1K |
| 94200 |
|
194 |
164 |
$997.34 |
| 00813 |
|
18 |
14 |
$990.00 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
148 |
140 |
$983.30 |
| 90677 |
|
3,298 |
3,151 |
$982.16 |
| 0124A |
|
63 |
52 |
$955.66 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,583 |
2,293 |
$955.50 |
| 99458 |
|
364 |
327 |
$947.13 |
| 96127 |
|
290 |
248 |
$941.68 |
| 84432 |
|
91 |
77 |
$930.13 |
| 87015 |
|
228 |
167 |
$920.57 |
| 81370 |
|
16 |
12 |
$907.02 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
901 |
506 |
$906.45 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
29 |
24 |
$891.55 |
| 83701 |
|
45 |
37 |
$877.09 |
| 86341 |
|
662 |
384 |
$876.02 |
| 99401 |
|
44 |
36 |
$875.06 |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
1,147 |
595 |
$863.82 |
| 86705 |
|
126 |
110 |
$845.84 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
2,149 |
1,678 |
$784.38 |
| 84520 |
|
187 |
156 |
$774.60 |
| 93926 |
|
13 |
13 |
$773.71 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
114 |
92 |
$764.84 |
| 96118 |
|
43 |
29 |
$763.46 |
| 51784 |
|
43 |
36 |
$744.36 |
| 82955 |
|
111 |
104 |
$733.67 |
| 58300 |
|
16 |
12 |
$731.62 |
| 93226 |
|
16 |
13 |
$728.40 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
4,656 |
3,463 |
$714.97 |
| 85520 |
|
70 |
51 |
$706.18 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
263 |
227 |
$704.70 |
| 73650 |
|
24 |
13 |
$699.65 |
| 76776 |
|
32 |
25 |
$699.11 |
| 0001A |
|
54 |
44 |
$697.81 |
| 87076 |
|
135 |
78 |
$676.71 |
| 87901 |
|
632 |
570 |
$676.34 |
| 82787 |
|
30 |
27 |
$664.39 |
| 00520 |
|
19 |
12 |
$662.20 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
99 |
48 |
$661.56 |
| 96138 |
|
263 |
245 |
$651.55 |
| 84630 |
|
80 |
74 |
$650.76 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
365 |
308 |
$635.54 |
| 88350 |
|
23 |
12 |
$634.91 |
| J7510 |
Prednisolone oral, per 5 mg |
2,020 |
1,420 |
$632.92 |
| Q9968 |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
15 |
12 |
$630.10 |
| 99195 |
|
14 |
12 |
$626.50 |
| 00635 |
|
14 |
12 |
$625.23 |
| 86664 |
|
66 |
43 |
$625.15 |
| 95012 |
|
404 |
362 |
$622.66 |
| 82952 |
|
221 |
191 |
$620.22 |
| 88177 |
|
147 |
126 |
$598.04 |
| G0008 |
Administration of influenza virus vaccine |
471 |
467 |
$568.38 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
19 |
12 |
$566.72 |
| 90698 |
|
5,007 |
4,659 |
$565.60 |
| 93978 |
|
34 |
15 |
$564.73 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,447 |
2,232 |
$557.81 |
| 95941 |
|
13 |
12 |
$552.00 |
| 93270 |
|
17 |
15 |
$547.06 |
| 86335 |
|
65 |
62 |
$546.09 |
| 86618 |
|
38 |
30 |
$539.67 |
| 86663 |
|
66 |
43 |
$536.44 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
65 |
29 |
$534.14 |
| 72080 |
|
15 |
12 |
$528.56 |
| Q4008 |
Cast supplies, long arm cast, pediatric (0-10 years), fiberglass |
48 |
40 |
$527.07 |
| 85049 |
|
151 |
80 |
$522.14 |
| V5011 |
Fitting/orientation/checking of hearing aid |
2,812 |
2,362 |
$521.10 |
| 95938 |
|
13 |
12 |
$515.71 |
| 87529 |
|
22 |
12 |
$512.46 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
664 |
514 |
$507.63 |
| 75774 |
|
134 |
123 |
$507.48 |
| 82040 |
|
191 |
154 |
$503.66 |
| 86769 |
|
13 |
13 |
$498.04 |
| 84154 |
|
41 |
38 |
$494.24 |
| 64494 |
|
1,011 |
870 |
$460.39 |
| 74021 |
|
20 |
17 |
$460.08 |
| 87184 |
|
95 |
80 |
$457.36 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
7,967 |
3,108 |
$455.47 |
| 99307 |
|
143 |
138 |
$449.53 |
| G0452 |
Molecular pathology procedure; physician interpretation and report |
16 |
16 |
$448.54 |
| V2020 |
Frames, purchases |
116 |
82 |
$448.11 |
| 80169 |
|
46 |
40 |
$438.41 |
| 0173A |
|
23 |
13 |
$433.53 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,409 |
2,098 |
$420.65 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
2,206 |
1,825 |
$415.51 |
| 99091 |
|
58 |
54 |
$415.23 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
19 |
18 |
$396.66 |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
185 |
181 |
$395.96 |
| 87181 |
|
74 |
60 |
$394.33 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,078 |
1,724 |
$391.20 |
| V5160 |
Dispensing fee, binaural |
44 |
15 |
$390.00 |
| 0077U |
|
474 |
428 |
$388.96 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
136 |
112 |
$384.43 |
| 83020 |
|
33 |
33 |
$382.33 |
| 81408 |
|
92 |
69 |
$379.71 |
| 78582 |
|
14 |
13 |
$375.59 |
| 90647 |
|
7,630 |
7,018 |
$374.33 |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
147 |
75 |
$363.30 |
| 95718 |
|
16 |
13 |
$353.82 |
| J9250 |
Methotrexate sodium, 5 mg |
646 |
348 |
$353.48 |
| 87209 |
|
26 |
25 |
$348.90 |
| C1780 |
Lens, intraocular (new technology) |
29 |
27 |
$348.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
2,955 |
2,144 |
$344.43 |
| 99251 |
|
18 |
14 |
$326.81 |
| 83090 |
|
36 |
29 |
$320.46 |
| 90700 |
|
114 |
89 |
$320.00 |
| 87641 |
|
13 |
12 |
$313.14 |
| 99156 |
|
16 |
14 |
$298.33 |
| 90714 |
|
2,366 |
1,958 |
$295.26 |
| 90688 |
|
23 |
23 |
$291.34 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
4,239 |
1,850 |
$287.99 |
| 87400 |
|
28 |
14 |
$281.76 |
| 82626 |
|
13 |
12 |
$277.43 |
| 87305 |
|
51 |
24 |
$274.23 |
| 99453 |
|
96 |
95 |
$272.16 |
| 81511 |
|
1,202 |
1,039 |
$272.00 |
| 86645 |
|
23 |
14 |
$265.11 |
| J9190 |
Injection, fluorouracil, 500 mg |
36 |
13 |
$264.73 |
| 00811 |
|
14 |
12 |
$263.03 |
| 36247 |
|
439 |
328 |
$262.27 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,377 |
2,281 |
$261.20 |
| 90707 |
|
1,272 |
1,107 |
$241.83 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
27,666 |
22,314 |
$237.96 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
635 |
520 |
$236.88 |
| A4648 |
Tissue marker, implantable, any type, each |
991 |
871 |
$236.00 |
| 77003 |
|
14 |
13 |
$235.83 |
| 93244 |
|
18 |
18 |
$234.87 |
| 86648 |
|
12 |
12 |
$225.24 |
| A9901 |
Dme delivery, set up, and/or dispensing service component of another hcpcs code |
52 |
43 |
$225.00 |
| D0210 |
Intraoral - complete series of radiographic images |
13 |
13 |
$222.66 |
| C1889 |
Implantable/insertable device, not otherwise classified |
60 |
52 |
$220.84 |
| 36568 |
|
19 |
12 |
$217.59 |
| 58340 |
|
18 |
12 |
$210.30 |
| 95806 |
|
14 |
13 |
$203.25 |
| 88240 |
|
37 |
13 |
$195.68 |
| 84145 |
|
579 |
476 |
$187.26 |
| G0425 |
Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth |
44 |
31 |
$186.90 |
| 86687 |
|
32 |
27 |
$183.40 |
| D1206 |
Topical application of fluoride varnish |
27 |
24 |
$181.83 |
| 93018 |
|
38 |
36 |
$181.22 |
| 84075 |
|
47 |
43 |
$178.38 |
| 87177 |
|
26 |
25 |
$174.47 |
| 93016 |
|
75 |
54 |
$172.62 |
| 51736 |
|
28 |
24 |
$169.53 |
| 99241 |
|
15 |
14 |
$163.70 |
| 80184 |
|
15 |
12 |
$151.47 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
14 |
12 |
$148.86 |
| 80156 |
|
13 |
12 |
$144.69 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
874 |
736 |
$142.18 |
| 86008 |
|
80 |
66 |
$132.85 |
| 97535 |
Self-care/home management training, each 15 minutes |
496 |
279 |
$129.91 |
| 87350 |
|
12 |
12 |
$128.07 |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
13 |
13 |
$126.88 |
| 92250 |
|
26 |
12 |
$121.80 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
631 |
517 |
$117.89 |
| 82270 |
|
30 |
25 |
$117.51 |
| 90685 |
|
314 |
284 |
$114.85 |
| 99226 |
|
183 |
124 |
$113.46 |
| 64999 |
|
19 |
13 |
$112.25 |
| 93291 |
|
13 |
13 |
$108.59 |
| 88334 |
|
16 |
12 |
$106.96 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
419 |
222 |
$106.88 |
| 80186 |
|
15 |
12 |
$104.93 |
| 93248 |
|
13 |
12 |
$102.70 |
| G0453 |
Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) |
19 |
12 |
$90.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
171 |
117 |
$85.52 |
| A6261 |
Wound filler, gel/paste, per fluid ounce, not otherwise specified |
93 |
67 |
$85.28 |
| 95982 |
|
13 |
12 |
$85.11 |
| 86005 |
|
12 |
12 |
$82.85 |
| 92583 |
|
29 |
26 |
$81.25 |
| 90474 |
|
14 |
12 |
$79.92 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
2,778 |
2,134 |
$78.10 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
343 |
180 |
$75.20 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
104 |
67 |
$70.46 |
| 92594 |
|
108 |
94 |
$69.69 |
| 36592 |
|
765 |
375 |
$69.68 |
| 84300 |
|
33 |
24 |
$69.12 |
| 82525 |
|
14 |
14 |
$67.81 |
| 82540 |
|
26 |
13 |
$61.32 |
| 87220 |
|
12 |
12 |
$55.63 |
| 75716 |
|
12 |
12 |
$55.02 |
| 80321 |
|
119 |
104 |
$53.01 |
| 0346T |
|
351 |
316 |
$48.81 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
26 |
12 |
$42.45 |
| D1208 |
Topical application of fluoride, excluding varnish |
12 |
12 |
$38.10 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
941 |
806 |
$36.33 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
117 |
99 |
$34.90 |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
24 |
14 |
$33.63 |
| L4387 |
Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf |
14 |
14 |
$31.94 |
| G9171 |
Voice functional limitation, current status at therapy episode outset and at reporting intervals |
113 |
99 |
$28.70 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,323 |
673 |
$24.96 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
434 |
150 |
$23.33 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
28 |
13 |
$21.10 |
| A6206 |
Contact layer, sterile, 16 sq. in. or less, each dressing |
17 |
13 |
$20.55 |
| 90739 |
|
33 |
26 |
$19.47 |
| A7507 |
Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each |
263 |
230 |
$16.12 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
568 |
446 |
$15.55 |
| 81596 |
|
353 |
318 |
$11.47 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
45 |
44 |
$9.60 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
62 |
25 |
$6.27 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
73 |
52 |
$0.70 |
| 90681 |
|
5,156 |
4,825 |
$0.00 |
| C1729 |
Catheter, drainage |
2,263 |
1,564 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
14 |
12 |
$0.00 |
| 77062 |
|
198 |
170 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
564 |
486 |
$0.00 |
| 0502F |
|
7,838 |
5,764 |
$0.00 |
| 64495 |
|
269 |
248 |
$0.00 |
| 86015 |
|
15 |
12 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,561 |
341 |
$0.00 |
| 3078F |
|
324 |
292 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
85 |
74 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
1,201 |
485 |
$0.00 |
| 3077F |
|
360 |
329 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
405 |
350 |
$0.00 |
| 64636 |
|
25 |
25 |
$0.00 |
| G0473 |
Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes |
79 |
70 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
924 |
669 |
$0.00 |
| 94667 |
|
82 |
72 |
$0.00 |
| C2628 |
Catheter, occlusion |
210 |
152 |
$0.00 |
| C1714 |
Catheter, transluminal atherectomy, directional |
148 |
137 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
87 |
81 |
$0.00 |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
14 |
14 |
$0.00 |
| 3046F |
|
99 |
85 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
58 |
54 |
$0.00 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
68 |
65 |
$0.00 |
| 76810 |
|
66 |
51 |
$0.00 |
| 81401 |
|
62 |
55 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
233 |
183 |
$0.00 |
| P9073 |
Platelets, pheresis, pathogen-reduced, each unit |
58 |
29 |
$0.00 |
| 87631 |
|
54 |
42 |
$0.00 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
23 |
12 |
$0.00 |
| 76376 |
|
22 |
15 |
$0.00 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
26 |
25 |
$0.00 |
| C1765 |
Adhesion barrier |
18 |
13 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
15 |
13 |
$0.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
13 |
12 |
$0.00 |
| V5261 |
Hearing aid, digital, binaural, bte |
12 |
12 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
411 |
236 |
$0.00 |
| C2623 |
Catheter, transluminal angioplasty, drug-coated, non-laser |
19 |
17 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,390 |
2,112 |
$0.00 |
| 3008F |
|
8,899 |
8,361 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
541 |
484 |
$0.00 |
| 90744 |
|
1,475 |
1,417 |
$0.00 |
| 99024 |
|
3,489 |
2,569 |
$0.00 |
| 90680 |
|
3,186 |
3,018 |
$0.00 |
| 90723 |
|
11,252 |
10,619 |
$0.00 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
184 |
161 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
413 |
321 |
$0.00 |
| 0500F |
|
348 |
330 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
1,401 |
1,121 |
$0.00 |
| 94668 |
|
952 |
422 |
$0.00 |
| C1877 |
Stent, non-coated/non-covered, without delivery system |
198 |
134 |
$0.00 |
| 77417 |
|
28 |
12 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
117 |
99 |
$0.00 |
| 90716 |
|
999 |
898 |
$0.00 |
| 3048F |
|
12 |
12 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
2,729 |
2,484 |
$0.00 |
| 3080F |
|
280 |
252 |
$0.00 |
| 90697 |
|
1,247 |
1,077 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
103 |
100 |
$0.00 |
| 3351F |
|
164 |
154 |
$0.00 |
| 3074F |
|
311 |
283 |
$0.00 |
| 97804 |
|
127 |
102 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
338 |
224 |
$0.00 |
| 3075F |
|
66 |
56 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
429 |
338 |
$0.00 |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
74 |
54 |
$0.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
99 |
67 |
$0.00 |
| G9172 |
Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
113 |
99 |
$0.00 |
| 3079F |
|
186 |
168 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
70 |
39 |
$0.00 |
| 3044F |
|
37 |
35 |
$0.00 |
| G8986 |
Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting |
48 |
46 |
$0.00 |
| C1734 |
Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable) |
36 |
25 |
$0.00 |
| 49424 |
|
47 |
40 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
114 |
92 |
$0.00 |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
74 |
50 |
$0.00 |
| C2618 |
Probe/needle, cryoablation |
60 |
52 |
$0.00 |
| 0503F |
|
787 |
713 |
$0.00 |
| C1781 |
Mesh (implantable) |
158 |
126 |
$0.00 |
| G9173 |
Voice functional limitation, discharge status at discharge from therapy or to end reporting |
113 |
99 |
$0.00 |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
16 |
12 |
$0.00 |
| 11045 |
|
27 |
25 |
$0.00 |
| 76812 |
|
32 |
25 |
$0.00 |
| 90378 |
|
41 |
30 |
$0.00 |
| 96139 |
|
55 |
52 |
$0.00 |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
13 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
18 |
12 |
$0.00 |
| A0434 |
Specialty care transport (sct) |
14 |
13 |
$0.00 |
| 3353F |
|
13 |
12 |
$0.00 |
| 90619 |
|
45 |
35 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
23 |
14 |
$0.00 |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
34 |
12 |
$0.00 |